Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.
La Jolla, San Diego
Joined June 2017
- Tweets51
- Following41
- Followers69
- Likes2
MatriSys announces positive results from a study of S. felis for the treatment of drug-resistant S. pseudintermedius. bit.ly/3aTYwlZ bit.ly/3DYNU1u #dermatology #skinmicrobiome
Dr. Philippe Calais, CEO of @MatriSysBio, will be presenting at the @MicrobiomeDaily 4th Microbiome Movement – Skin Health & Dermatology Summit (microbiome-dermatology.com/) on August 4th at 4:15 p.m. ET. bit.ly/2VdKjLY
We are pleased to announce that Dr. Joyce Rico is joining MatriSys as Chief Medical Officer. Dr. Rico’s 20 years of experience in early and late-stage #dermatology drug development, product launch, and drug safety is a welcome addition to our team.
MatriSys Bioscience licenses compound for harnessing beneficial bacteria to treat #acne, building upon company pipeline targeting inflammatory skin diseases. bit.ly/3rZ2ro9 #dermatology #skinmicrobiome
MatriSys Bioscience raises more than $3 million to advance its platform developing #skinmicrobiome therapies for inflammatory skin diseases. #dermatology
Published @NatureMedicine study on @MatriSysBio’s lead compound for #atopicdermatitis reveals the potential of beneficial bacteria to treat chronic skin diseases. bit.ly/3qOt92g #dermatology #microbiome
Buzz of Bio!! Vote for us!!
How to vote for us:
Go here: convention.bio.org/buzzofbio…
Complete each field on the right side of the page
Be sure to select MatriSys Bioscience under Pipelines of Promise
Hit submit
Follow the link in the confirmation email to verify your vote
